Works matching IS 10568751 AND DT 2012 AND VI 157 AND IP 4
Results: 12
2012 - 24- and 6-month dual antiplatelet therapy after coronary stenting did not differ for clinical outcomes.
- Published in:
- ACP Journal Club, 2012, v. 157, n. 4, p. 1, doi. 10.7326/0003-4819-157-4-201208210-02009
- By:
- Publication type:
- Article
2012 - Review: Proton-pump inhibitors are associated with increased risk for Clostridium difficile infection.
- Published in:
- ACP Journal Club, 2012, v. 157, n. 4, p. 1, doi. 10.7326/0003-4819-157-4-201208210-02013
- By:
- Publication type:
- Article
2012 - Review: Bedside ultrasonography has 82% sensitivity and 99% specificity for blunt intraabdominal injury.
- Published in:
- ACP Journal Club, 2012, v. 157, n. 4, p. 1, doi. 10.7326/0003-4819-157-4-201208210-02012
- By:
- Publication type:
- Article
2012 - Review: Prophylactic botulinum toxin A reduces frequency of chronic migraine headaches in adults.
- Published in:
- ACP Journal Club, 2012, v. 157, n. 4, p. 1, doi. 10.7326/0003-4819-157-4-201208210-02010
- By:
- Publication type:
- Article
2012 - Review: Antiplatelet therapy does not reduce mortality in chronic kidney disease.
- Published in:
- ACP Journal Club, 2012, v. 157, n. 4, p. 1, doi. 10.7326/0003-4819-157-4-201208210-02008
- By:
- Publication type:
- Article
2012 - Warfarin and aspirin did not differ for death or stroke in heart failure and sinus rhythm.
- Published in:
- ACP Journal Club, 2012, v. 157, n. 4, p. 1, doi. 10.7326/0003-4819-157-4-201208210-02007
- By:
- Publication type:
- Article
2012 - Drotrecogin alfa (activated) did not reduce mortality at 28 or 90 days in patients with septic shock.
- Published in:
- ACP Journal Club, 2012, v. 157, n. 4, p. 1, doi. 10.7326/0003-4819-157-4-201208210-02011
- By:
- Publication type:
- Article
2012 - Review: Factor Xa inhibitors reduce DVT more than LMWH in total knee or hip replacement.
- Published in:
- ACP Journal Club, 2012, v. 157, n. 4, p. 1, doi. 10.7326/0003-4819-157-4-201208210-02005
- By:
- Publication type:
- Article
Review: Fondaparinux reduces VTE and recurrence in superficial thrombophlebitis of the leg.
- Published in:
- ACP Journal Club, 2012, v. 157, n. 4, p. 1, doi. 10.7326/0003-4819-157-4-201208210-02004
- By:
- Publication type:
- Article
2012 - Review: Omega-3 fatty acid supplements provide no protective benefit in cardiovascular disease.
- Published in:
- ACP Journal Club, 2012, v. 157, n. 4, p. 1, doi. 10.7326/0003-4819-157-4-201208210-02003
- By:
- Publication type:
- Article
2012 - Review: Varenicline for tobacco cessation does not increase CV serious adverse events.
- Published in:
- ACP Journal Club, 2012, v. 157, n. 4, p. 1, doi. 10.7326/0003-4819-157-4-201208210-02002
- By:
- Publication type:
- Article
2012 - Rivaroxaban and usual care had similar rates of recurrent VTE and bleeding in symptomatic PE.
- Published in:
- ACP Journal Club, 2012, v. 157, n. 4, p. 1, doi. 10.7326/0003-4819-157-4-201208210-02006
- By:
- Publication type:
- Article